Company Filing History:
Years Active: 2001-2003
Title: Keegan Cooke: Innovator in Retroviral Technology
Introduction
Keegan Cooke is a prominent inventor based in Palo Alto, CA, known for his significant contributions to the field of retroviral technology. With a focus on enhancing the efficiency of viral transduction methods, Cooke has developed innovative solutions that have the potential to advance gene therapy and related applications.
Latest Patents
Cooke holds 2 patents, including a groundbreaking invention titled "Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells." This invention introduces a novel retroviral packaging system that allows for the production of high titers of recombinant retrovirus in mammalian cells. The method enables the transduction of mammalian target cells through cocultivation or supernatant infection, achieving high efficiencies. This technology is particularly useful for rapidly producing high titer viral supernatants and transducing cells that are typically resistant to conventional transduction methods.
Career Highlights
Keegan Cooke has made significant strides in his career, particularly through his work at Cell Genesys, Inc. His innovative approaches have positioned him as a key figure in the development of advanced retroviral systems, contributing to the broader field of gene therapy.
Collaborations
Throughout his career, Cooke has collaborated with notable professionals in the field, including Mitchell H. Finer and Krisztina M. Zsebo. These collaborations have further enhanced the impact of his work and have contributed to advancements in retroviral technology.
Conclusion
Keegan Cooke's contributions to retroviral technology exemplify the innovative spirit of modern science. His patents and work at Cell Genesys, Inc. highlight the importance of advancements in gene therapy and the potential for future breakthroughs in the field.